Description: Panelists discuss: [1] the tax implication of NAIC changes to reserving requirements, [2] the new NAIC Valuation of Life Insurance Policies Model Regulation [Reg. XXX], [3] Actuarial Guideline 33 [AG 33], [4] AG 34, and [5] highlights of an actual IRS audit involving these NAIC actuarial guidelines and regulations. From the 1997 Record of Society of Actuaries, Vol. 23, No. 3.

Description: This session at the SOA 1990 Hartford Spring Meeting covers current reserving requirements for AIDS in the U.S., Canada, and the U. K. Case studies are presented that look at evaluating the AIDS risk and determining the necessary reserves and surplus for the extra mortality.

Description: This 1977 panel discussion focused on the implications of proposed revisions of the standard valuation and nonforfeiture laws. Areas discussed included: 1. A regulator's perspective 2. Applications to Life and Annuities 3. applications to Pensions

Description: Discusses mortality improvements over the last 20 years, the extent to which premiums on nonparticipating policies reflect the changes in mortality experience, the proposed new valuation table, should valuation tables be split by gender, and extra mortality on substandard lives at very long durations.

Description: 2003 Valuation Actuary Symposium, San Diego, CA. This session provided an overview of current statutory valuation issues pertaining to life and annuity products. Topics included: 1. Actuarial opinion and memorandum regulation amendments. 2. Progress on variable products reserving standards. 3. Regulation XXX mortality factors. 4. Adoption of the 2001 CSO. 5. Progress on the C-3 Phase II RBC project. 6. An update on annuity and life nonforfeiture.

Description: 1996 Valuation Actuary Symposium. This session about life and annuity valuation issues discussed Guideline 33, Guideline MMM, separate accont surplus, equity-indexed annuities, the annuity mortality regulation, the model illustration regulation, and XXX.

Description: This session at the 2004 Valuation Actuary Symposium provides an overview of statutory valuation issues for life and annuity products including the Actuarial Opinion and Memorandum Regulation, variable products reserving standard, adoption of 2001 CSO, C-3 Phase II RBC project and nonforfeiture changes.

Description: This 1979 session is about the New Valuation Mortality Tables for Individual Life Insurance. Topics included: I. The Recommendation of Sex-distinct Tables 2. The Development of Basic Tables - Data Selection, Construction, Graduation 3. Margins and the Development of Loaded Tables 4. Implications for the Industry

Description: Panelists at this session of the SOA 1991 Toronto Spring Meeting give an overview of Regulation XXX including its effect on product design, proposed actuarial guidelines, 2001 CSO, X-factor analysis and reinsurance issues.

Description: The valuation manual is a living document that continues to evolve. As more companies adopt Principle-Based Reserving (PBR) and file PBR Actuarial Reports, regulators have observed gaps and inconsistencies across the industry. As a result, PBR reporting requirements (VM-31) have expanded significantly in 2020 and still continue to evolve. This session will provide attendees with everything they need to fill out their PBR reports for both Life business and Variable Annuity business. We will dig into the new changes effective for 2020 reporting and approved changes for 2021, and compare and contrast the Life and VA requirements to help companies identify areas that can be leveraged between the two. In addition, we will share insights from regulators, consultants, and company actuaries on what to include or exclude in your report.